Transient Receptor Potential Ankyrin type 1 (TRPA1) is a cation-selective ion channel that is activated by several noxious compounds and by reduced temperature. Given its role in noxious sensation and inflammation, TRPA1 has become an active drug target for the treatment of pain and inflammation-related ailments such as itch and cough. Although the cryo-EM structure of TRPA1 has provided a starting point in understanding channel activation, the structural mechanisms remain elusive. In particular, an N-terminal Ankyrin Repeat Domain (ARD) contains a highly reactive cysteine that activates TRPA1 demonstrating the importance of this region in channel function. Furthermore, it was hypothesized that a tetrameric C-terminal coiled-coil was stabilized by a polyphosphate compound, IP6, which would account for the requirement of polyphosphates in excised patch electrophysiology experiments recording TRPA1 activity. Here, we used biochemical and biophysical approaches of isolated cytoplasmic domains from human TRPA1 to probe the role of IP6 on the oligomerization of N-terminal ARD and the C-terminal coiled-coil. Surprisingly, we found that oligomerization of the C-terminal coiled-coil was indistinguishable in the absence and presence of IP6. IP6 similarly had no discernable effect on binding of the ARD to the C-terminal coiled-coil. Our data suggest that the role of IP6 in TRPA1 activation likely involves mechanisms not yet considered.
Read full abstract